Menu
Not yet recruiting NCT07396389

Understanding How Young Adults Perceive Blurred Image Quality and Creating a Model Predicting Their Quality Ratings

No phase Interventional Healthy Young Adults

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: eye exam, image rating.
Who it may be relevant to
Registry conditions: Healthy Young Adults. Basic parameters: 18 years — 30 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
France
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Modèle de Performance Subjective Généralisé

Overview

This clinical study wants to understand how blurred images look to young adults. The main question is: How do different kinds of images and different kinds of blur change the way people think those images look? Participants will get an eye exam, then look at several blurred images and rate how good or bad each one looks on a quality scale from 1 (very bad) to 10 (very good).

Interventions

  • Device eye exam
    participants will follow a complete eye exam
  • Other image rating
    participants will have to rate the perceived quality of images on a 10 points scale

Primary outcome measures

  • Subjective image quality rating on a quality scale from 1 (very bad) to 10 (very good) [Time frame: Day one]

Eligibility criteria

Inclusion criteria

  • Distance refractive error (equivalent sphere) between -7 D and +5 D
  • Astigmatism below 4D
  • Minimum corrected visual acuity: 10/10

Exclusion criteria

  • Aphakic or pseudophakic eye surgery
  • Reported systemic pathology that affects vision
  • Medical treatment or taking medications that affect vision
  • Severe ocular pathology declared, involving a loss of visual field as in glaucoma, a loss of acuity
  • Reported neurological deficit, including a history of seizure or sensorimotor coordination disorders, vestibular or cerebellar pathology
  • Binocular vision problems such as amblyopia, strabismus, or double vision

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Basic science

Study locations

France · 1 center
  • LABORATOIRE LuMIn - ENS Paris-Saclay — Gif-sur-Yvette

Identifiers

NCT: NCT07396389 · WS10490 · 2025-A02625-44

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗